ngt-pharma-masthead

Customized Solutions for Complex Challenges

NGT BioPharma Consultants Leadership Team

Michael K. O’Brien, PhD
President & CEO
Mark Zettler, PhD
Executive VP Operations

Daniel Schaufelberger, PhD
VP Chemistry, Manufacturing & Controls​
Michelle McGuinness, MS
VP Regulatory Strategy & Submissions
Michael J. Neeb, PhD
VP Preclinical Development
Ronay LeBlanc, MA
VP Quality & Compliance
Francois Menard, PhD
VP Business Innovation
Clinical Development
Leadership In Transition
Rachel Franckowiak, BA
Senior Executive Administrator
David Lowenschuss, JD 
VP General Counsel
Michael Placke, PhD, DABT
Michael Placke, PhD, DABT
Nonclinical Development & Drug Safety
Malcolm Berry, PhD - Multi-Stage Continuous Processing for APIs
 
Malcolm Berry, PhD
API Continuous Processing
Michael Placke, NGT Biopharma Consultants
 
Michael Placke, PhD, DABT
Nonclinical Development
and Drug Safety